Vitamin D3: The Deficiency You Probably Have, Why the Standard Range Is Probably Wrong, and What to Take
Vitamin D deficiency is estimated to affect 40–80% of adults in northern latitudes. The standard sufficiency threshold (50 nmol/L serum 25(OH)D) is set for bone health. For immune function, mortality risk, and chronic disease prevention, the evidence points to a higher target. Here's the mechanism and the evidence.
Vitamin D is not technically a vitamin — it is a prohormone, produced in skin by UV-B radiation acting on 7-dehydrocholesterol, then hydroxylated in the liver (25-hydroxyvitamin D, the storage form measured in blood) and again in the kidney (1,25-dihydroxyvitamin D, the active form). The target cells: essentially every cell in the body, via vitamin D receptors (VDRs) — among the most broadly distributed nuclear receptors in human physiology.
The Deficiency Epidemic
Vitamin D deficiency is estimated at:
- 40% of the US adult population (by the sufficiency criterion of 50 nmol/L)
- 70–80% in Northern European and Scandinavian populations in winter
- Nearly universal in populations spending most daylight hours indoors, regardless of latitude
The primary source is cutaneous synthesis. Dietary vitamin D (from fatty fish, eggs, fortified foods) contributes a minority of total requirement in sun-exposed populations. For those with minimal sun exposure, diet is functionally the only source — and across most populations, dietary sources are not enough to maintain sufficiency.
What Vitamin D Does
Bone metabolism: The classical function. Active vitamin D is required for intestinal calcium absorption and bone mineralization. Deficiency reduces calcium absorption, increases bone turnover to maintain serum calcium, and decreases bone density. Rickets (children), osteomalacia (adults), and osteoporosis are the end-stage conditions.
Immune function: VDRs are expressed on most immune cells. Active vitamin D modulates both innate and adaptive immunity — promoting antimicrobial peptide production in macrophages (cathelicidin, defensins), shifting T-cell differentiation toward regulatory rather than inflammatory phenotypes, and suppressing excessive cytokine production. The epidemiological association between low vitamin D status and autoimmune disease is substantial.
Non-skeletal outcomes: Meta-analyses associate vitamin D deficiency with increased risk of cardiovascular disease, type 2 diabetes, certain cancers (particularly colorectal), all-cause mortality, and depression. Causality remains debated for some endpoints, but the all-cause mortality data is particularly robust.
> 📌 Autier et al. (2014) reviewed 172 observational studies and found consistent inverse associations between serum 25(OH)D and multiple disease outcomes, but noted that supplementation RCTs showed smaller or absent effects — suggesting low vitamin D may partly be a marker of ill health and inflammation (reverse causality) rather than purely a cause. More recent RCTs using higher doses show significant effects on some endpoints, and the mortality data remains strong. [1]
The Dosing Question
Standard supplement recommendations sit at 400–800 IU/day. This is nearly universally inadequate for maintaining serum 25(OH)D above 50 nmol/L without sun exposure.
Functional doses for maintaining an optimal range (75–125 nmol/L by most authorities):
- 1,000–2,000 IU/day for maintenance in mildly deficient individuals with some sun exposure
- 3,000–4,000 IU/day for correction and maintenance in clearly deficient individuals or those with minimal sun exposure
- Testing serum 25(OH)D is the definitive approach — dose to achieve 75–100 nmol/L
Take with the largest fat-containing meal of the day (D3 is fat-soluble). D3 (cholecalciferol) is superior to D2 (ergocalciferol) for raising and maintaining serum levels.
---